|
|
|
|
LEADER |
01138naa a2200277 i 4500 |
001 |
NSK01001156632 |
003 |
HR-ZaNSK |
005 |
20221207143218.0 |
007 |
ta |
008 |
190410s2020 ci | |0|| ||eng |
035 |
|
|
|a (HR-ZaNSK)001156632
|
040 |
|
|
|a HR-ZaNSK
|b hrv
|c HR-ZaNSK
|e ppiak
|
042 |
|
|
|a croatica
|
044 |
|
|
|a ci
|c hr
|
080 |
1 |
|
|a 615
|2 2011
|
080 |
1 |
|
|a 616
|2 2011
|
100 |
1 |
|
|a Zhou, Peng
|4 aut
|9 HR-ZaNSK
|
245 |
1 |
0 |
|a Prediction of drug-drug plasma protein binding interactions of resveratrol in combination with celecoxib and leflunomide by molecular docking combined with an ultrafiltration technique /
|c Peng Zhou, Fang Hua.
|
300 |
|
|
|b Graf. prikazi.
|
504 |
|
|
|a Bibliografija: 15 jed.
|
653 |
|
0 |
|a Reumatoidni artritis
|a Kombinacije lijekova
|a Resveratrol
|a Celekoksib
|a Leflunomid
|a Molekularno pristajanje
|a Proteini plazme
|a Ultrafiltracija
|a Pokusni štakori
|
700 |
1 |
|
|a Hua, Fang
|4 aut
|9 HR-ZaNSK
|
773 |
0 |
|
|t Acta pharmaceutica (Zagreb)
|x 1330-0075
|g 70 (2020), 1 ; str. 111-119
|w nsk.(HR-ZaNSK)000054908
|
981 |
|
|
|b B07/20
|
998 |
|
|
|b milo2212
|
856 |
4 |
1 |
|u https://hrcak.srce.hr/220885
|y Elektronička verzija članka
|